Sponsor:
M.D. Anderson Cancer Center
Code:
NCT06287229
Conditions
Relapsed/Refractory
B-cell Acute Lymphocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Blinatumomab
Inotuzumab Ozogamicin
Hyper-CVAD
Mini-hyper-CVD
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations